NSF Intl. Drinking Water Expert to Speak at WQA Aquatech USA
Rick Andrew will discuss the new draft standard on emerging compounds/incidental contaminants
Rick Andrew, director of the NSF Intl. Drinking Water Business Development Div., will discuss a new draft standard on emerging compounds/incidental contaminants at the WQA Aquatech USA tradeshow in Orlando, Fla., on Thursday, March 20, at 8 a.m. NSF 401 Drinking Water Treatment Units – Emerging Compounds/Incidental Contaminants establishes requirements designed to reduce emerging compounds, including pharmaceuticals, personal care products, chemicals and endocrine-disrupting compounds such as bisphenol A (BPA) in water.
The standard will focus on claims being made for the reduction of 15 individual compounds, including BPA, meprobamate, phenytoin, atenolol, carbamazepine, TCEP, TCPP, DEET, metolachlor, trimethoprim, ibuprofen, naproxen, estrone, linuron and nonyl phenol. This list of contaminants represents pharmaceutical, personal care and endocrine-disrupting compounds that have been identified in published studies as occurring in drinking water, and the claims are based on testing the actual compound in question.
Products covered in the standard include several types of drinking water treatment products, such as mouth-drawn and hand-squeezed sports bottle-type filtration systems, point-of-use reverse osmosis systems and traditional filtration systems.
The session is open to all registered attendees interested in learning more about NSF 401.